Effective suppression of testosterone: the best castration therapy for hormone-sensitive prostate cancer?

Androgen suppression strategy has become the key treatment of advanced prostate cancer. Historically, testosterone level below 1.73 nmol/l (50 ng/dl) was regarded as the castrate level. The current data shows that in an attempt to improve the therapeutic outcome, the new target for chemical castrati...

Descripció completa

Dades bibliogràfiques

Autors principals:	A. A. Gritskevich, S. V. Mishugin, A. A. Teplov, V. L. Medvedev, I. G. Rusakov
Format:	Artigo
Idioma:	Russo
Publicat:	Remedium Group LLC 2015-12-01
Col·lecció:	Медицинский совет
Matèries:	рак предстательной железы аналоги лютеинизирующего гормона рилизинг-гормон трипторелин тестостерон prostate cancer analogs of luteinizing hormone releasing hormone triptorelin testosterone
Accés en línia:	https://www.med-sovet.pro/jour/article/view/225
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!